Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine versus acetazolamide for prevention of intraocular pressure elevation after cataract surgery
ACTRN12609000553279Phase 4Not yet recruiting
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of brimonidine and acetazolamide in ocular hypertension (2 arms), sponsored by Sir Charles Gairdner Hospital. Primary endpoint: Intraocular pressure. Planned start Jul 2009; status: not yet recruiting.
02
Drugs
brimonidineacetazolamide
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on ACTRN12609000553279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000553279.